JP2023549124A5 - - Google Patents

Info

Publication number
JP2023549124A5
JP2023549124A5 JP2023527351A JP2023527351A JP2023549124A5 JP 2023549124 A5 JP2023549124 A5 JP 2023549124A5 JP 2023527351 A JP2023527351 A JP 2023527351A JP 2023527351 A JP2023527351 A JP 2023527351A JP 2023549124 A5 JP2023549124 A5 JP 2023549124A5
Authority
JP
Japan
Application number
JP2023527351A
Other languages
Japanese (ja)
Other versions
JPWO2022099007A5 (https=
JP2023549124A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/058255 external-priority patent/WO2022099007A1/en
Publication of JP2023549124A publication Critical patent/JP2023549124A/ja
Publication of JPWO2022099007A5 publication Critical patent/JPWO2022099007A5/ja
Publication of JP2023549124A5 publication Critical patent/JP2023549124A5/ja
Pending legal-status Critical Current

Links

JP2023527351A 2020-11-06 2021-11-05 難聴の治療のためのバリアントアデノ随伴ウイルス(aav)カプシドポリペプチド、及びその遺伝子治療薬 Pending JP2023549124A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063110697P 2020-11-06 2020-11-06
US63/110,697 2020-11-06
US202163146269P 2021-02-05 2021-02-05
US63/146,269 2021-02-05
PCT/US2021/058255 WO2022099007A1 (en) 2020-11-06 2021-11-05 Variant adeno-associated virus (aav)capsid polypeptides and gene therapeutics thereof for treatment of hearing loss

Publications (3)

Publication Number Publication Date
JP2023549124A JP2023549124A (ja) 2023-11-22
JPWO2022099007A5 JPWO2022099007A5 (https=) 2024-10-31
JP2023549124A5 true JP2023549124A5 (https=) 2024-10-31

Family

ID=81457402

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023527351A Pending JP2023549124A (ja) 2020-11-06 2021-11-05 難聴の治療のためのバリアントアデノ随伴ウイルス(aav)カプシドポリペプチド、及びその遺伝子治療薬

Country Status (8)

Country Link
US (1) US20240226330A9 (https=)
JP (1) JP2023549124A (https=)
KR (1) KR20230117731A (https=)
AU (1) AU2021376225A1 (https=)
CA (1) CA3197592A1 (https=)
IL (1) IL302653A (https=)
MX (1) MX2023005344A (https=)
WO (1) WO2022099007A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7807380B2 (ja) 2020-02-21 2026-01-27 アコーオス インコーポレイテッド ヒト対象において非加齢関連聴力障害を処置するための組成物および方法
WO2024164318A1 (zh) * 2023-02-10 2024-08-15 苏州星奥拓维生物技术有限公司 Gch1抑制剂在制备用于预防和治疗听力损伤的药物中的用途
CN116925239B (zh) * 2023-07-17 2024-10-18 苏州星奥拓维生物技术有限公司 双载体系统表达Otof基因的组合物和方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10294281B2 (en) * 2012-05-15 2019-05-21 University Of Florida Research Foundation, Incorporated High-transduction-efficiency rAAV vectors, compositions, and methods of use
US12054724B2 (en) * 2018-04-10 2024-08-06 President And Fellows Of Harvard College AAV vectors encoding clarin-1 or GJB2 and uses thereof
CN118497276A (zh) * 2018-11-07 2024-08-16 阿库斯股份有限公司 腺相关病毒载体用于在内耳中的毛细胞和支持细胞中校正基因缺陷/表达蛋白质的用途
WO2020148458A1 (en) * 2019-01-18 2020-07-23 Institut Pasteur Aav-mediated gene therapy restoring the otoferlin gene
CA3153133A1 (en) * 2019-09-30 2021-04-08 Chris Bartolome Adeno-associated virus (aav) systems for treatment of genetic hearing loss
CN111349148A (zh) * 2020-03-13 2020-06-30 辉大(上海)生物科技有限公司 一种腺相关病毒载体及其用途

Similar Documents

Publication Publication Date Title
JP2022549380A5 (https=)
JP2023549124A5 (https=)
CN305532992S (https=)
CN306362368S (https=)
CN305537023S (https=)
CN305536875S (https=)
CN306283308S (https=)
CN305536809S (https=)
CN306281877S (https=)
CN306279893S (https=)
CN305536452S (https=)
CN305536421S (https=)
CN305536403S (https=)
CN305535914S (https=)
CN305534692S (https=)
CN306278643S (https=)
CN305533482S (https=)
CN306277950S (https=)
CN305533435S (https=)
CN305532072S (https=)
CN305531491S (https=)
CN305531425S (https=)
CN305529483S (https=)
CN306277633S (https=)
CN305527236S (https=)